C
CHEMED CORP
CHECIK 0000019584NYSELarge AcceleratedServices-Home Health Care ServicesDelawareFY ends Dec 31
Period
FY 2025
Revenue
$2.53B
Net Income
$265.24M
Total Assets
$1.54B
Equity
$979.40M
Shares Out
13.27M
Op. Cash Flow
$388.27M
Business
CHEMED CORP purchases, operates and divests subsidiaries across diverse service businesses, managing day-to-day operations on a decentralized basis. Its main offerings are hospice and palliative care services through clinical teams and support networks, and plumbing, drain cleaning, excavation, water restoration and related home- and commercial-service offerings. The company operates through two reportable segments: VITAS (hospice and palliative care) and Roto-Rooter (plumbing and restoration services). Operations are conducted primarily across the United States via company-owned locations, franchises, contractor networks and direct patient/home-based care channels.
Summary from filing dated 2025-02-28
Financials
Consolidated Statement of Income
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Service revenues and sales (Note 2) | 2,530 | 2,431 | 2,264 | 2,135 | 2,139 | |
| Cost of services provided and goods sold (excluding depreciation) | 1,707 | 1,577 | 1,466 | 1,370 | 1,369 | |
| Selling, general and administrative expenses | 417 | 424 | 395 | 359 | 367 | |
| Depreciation | 55 | 53 | 51 | 49 | 49 | |
| Amortization | 10 | 10 | 10 | 10 | 10 | |
| Other operating expenses (Note 20) | 3 | 446,000 | 2 | 4 | 987,000 | |
| Total costs and expenses | 2,192 | 2,065 | 1,924 | 1,791 | 1,796 | |
| Income from operations | 338 | 366 | 341 | 343 | 343 | |
| Interest expense | −2 | −2 | −3 | −5 | −2 | |
| Other income - net (Note 10) | 19 | 35 | 13 | −9 | 9 | |
| Income before income taxes | 356 | 399 | 350 | 330 | 350 | |
| Income taxes (Note 11) | −91 | −97 | −78 | −80 | −82 | |
| Net Income | 265 | 302 | 273 | 250 | 269 | |
| Net Income (per share) | 18.42 | 20.1 | 18.11 | 16.72 | 17.14 | |
| Average number of shares outstanding | 14 | 15 | 15 | 15 | 16 | |
| Net Income (per share) | 18.34 | 19.89 | 17.93 | 16.53 | 16.85 | |
| Average number of shares outstanding | 14 | 15 | 15 | 15 | 16 |
Consolidated Balance Sheet
As of · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents (Note 9) | 75 | 178 | 264 | 74 | 33 | |
| Accounts receivable | 183 | 171 | 182 | 139 | 137 | |
| Inventories | 8 | 8 | 12 | 10 | 10 | |
| Prepaid income taxes | 11 | 11 | 13 | 19 | 17 | |
| Prepaid expenses | 27 | 26 | 30 | 30 | 33 | |
| Total current assets | 303 | 395 | 501 | 273 | 230 | |
| Investments of deferred compensation plans held in trust (Notes 15 and 17) | 140 | 131 | 106 | 93 | 99 | |
| Properties and equipment, at cost, less accumulated depreciation (Note 13) | 206 | 201 | 204 | 200 | 194 | |
| Lease right of use asset (Note 14) | 131 | 127 | 126 | 136 | 125 | |
| Identifiable intangible assets less accumulated amortization (Note 6) | 83 | 92 | 90 | 100 | 108 | |
| Goodwill | 667 | 667 | 585 | 581 | 579 | |
| Other assets (Note 12) | 9 | 56 | 56 | 60 | 8 | |
| Total Assets | 1,538 | 1,669 | 1,668 | 1,442 | 1,343 | |
| Accounts payable | 64 | 44 | 64 | 42 | 73 | |
| Accrued insurance | 62 | 57 | 59 | 59 | 56 | |
| Income taxes (Note 11) | 3 | 8 | 7 | — | 41,000 | |
| Accrued compensation | 58 | 92 | 88 | 87 | 96 | |
| Short-term lease liability (Note 14) | 41 | 42 | 39 | 39 | 38 | |
| Other current liabilities (Note 21) | 59 | 43 | 56 | 61 | 39 | |
| Total current liabilities | 287 | 286 | 312 | 297 | 302 | |
| Deferred income taxes (Note 11) | 19 | 26 | 30 | 39 | 23 | |
| Deferred compensation liabilities (Note 15) | 136 | 126 | 104 | 92 | 99 | |
| Long-term lease liability (Note 14) | 103 | 99 | 101 | 111 | 101 | |
| Other liabilities | 13 | 13 | 13 | 12 | 10 | |
| Total Liabilities | 559 | 550 | 560 | 643 | 719 | |
| Commitments and contingencies (Note 18) | — | — | — | — | — | |
| Capital stock - authorized 80,000,000 shares $1 par; issued 37,594,676 shares (2024 - 37,422,348 shares) | 38 | 37 | 37 | 37 | 37 | |
| Paid-in capital | 1,592 | 1,484 | 1,341 | 1,150 | 1,044 | |
| Retained earnings | 2,955 | 2,722 | 2,447 | 2,198 | 1,970 | |
| Treasury stock - 23,884,187 shares (2024 - 22,865,842 shares), at cost | −3,608 | −3,127 | −2,720 | −2,588 | −2,430 | |
| Deferred compensation payable in Company stock (Note 15) | 2 | 2 | 2 | 2 | 2 | |
| Total Stockholders' Equity | 979 | 1,119 | 1,108 | 799 | 623 | |
| Total Liabilities and Stockholders' Equity | 1,538 | 1,669 | 1,668 | 1,442 | 1,343 |
Consolidated Statement of Cash Flows
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 65 | 63 | 61 | 59 | 59 | |
| Stock option expense | 33 | 32 | 30 | 26 | 23 | |
| Benefit for deferred income taxes | −6 | −4 | −8 | 15 | 2 | |
| Noncash portion of long-term incentive compensation | 5 | 19 | 9 | 6 | 8 | |
| Litigation settlements | 1 | −6 | 2 | — | — | |
| Noncash directors' compensation | 1 | 1 | 1 | 1 | 1 | |
| Amortization of debt issuance costs | 321,000 | 321,000 | 580,000 | 342,000 | 306,000 | |
| (Increase)/decrease in accounts receivable | −12 | 11 | −41 | −2 | −8 | |
| Decrease/(increase) in inventories | 650,000 | 4 | −2 | −162,000 | −3 | |
| (Increase)/decrease in prepaid expenses | −844,000 | 4 | 87,000 | 2 | −7 | |
| Decrease in accounts payable and other current liabilities | −5 | −9 | −9 | 15 | 10 | |
| Change in current income taxes | −6 | 2 | 12 | −996,000 | −20 | |
| Net change in lease assets and liabilities | −806,000 | −674,000 | −1 | 1 | −44,000 | |
| Decrease/(increase) in other assets | 37 | −26 | −10 | −46 | −10 | |
| Increase in other liabilities | 10 | 23 | 13 | −3 | 12 | |
| Other sources | 459,000 | 2 | 836,000 | −26,000 | 1 | |
| Net cash provided by operating activities | 388 | 417 | 330 | 310 | 309 | |
| Capital expenditures | −63 | −50 | −57 | −57 | −59 | |
| Proceeds from sale of fixed assets | 5 | 3 | 640,000 | 2 | 904,000 | |
| Business combinations, net of cash acquired | −225,000 | −97 | −4 | −4 | — | |
| Other uses | −888,000 | −295,000 | −434,000 | −878,000 | 14,000 | |
| Net cash used by investing activities | −59 | −144 | −61 | −59 | −58 | |
| Purchases of treasury stock | −432 | −361 | −68 | −115 | −576 | |
| Dividends paid | −32 | −27 | −24 | −22 | −22 | |
| Proceeds from exercise of stock options | 27 | 57 | 102 | 45 | 36 | |
| Change in cash overdraft payable | 11 | −16 | 16 | −12 | 12 | |
| Capital stock surrendered to pay taxes on stock-based compensation | −9 | −9 | −10 | −16 | −15 | |
| Payments on other long-term debt | — | — | −98 | −3 | — | |
| Other sources/(uses) | 1 | −2 | 490,000 | −1 | −165,000 | |
| Net cash used by financing activities | −433 | −359 | −80 | −209 | −381 | |
| (Decrease)/increase in cash and cash equivalents | −104 | −86 | 190 | 41 | −130 |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro